Related Experiment Video
Updated: Jul 8, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Radiosensitization of prostate cancer by soy isoflavones
Julian J Raffoul1, Fazlul H Sarkar, Gilda G Hillman
1Department of Radiation Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Abstract:
A trend in investigating the use of several nutritional compounds for cancer chemoprevention has revealed that phytochemicals demonstrated anti-cancer properties by inhibiting signal transduction pathways essential for cancer cell proliferation, tumor growth, invasion and metastasis. Emerging evidence suggests that the anti-proliferative and anti-oxidant effects of some of these dietary agents could be utilized to both potentiate the response of cancer cells to radiotherapy and reduce radiation-induced toxicity to normal surrounding tissues. Using pre-clinical orthotopic models of prostate cancer, studies on the combination of soy isoflavones with tumor irradiation demonstrate a synergistic anti-cancer effect between these two modalities and emphasize the potential and safety of dietary factors to improve conventional radiotherapy for a better control of tumor growth and metastasis. The goal of this review is to focus on the role of soy isoflavones as potent radiosensitizers for prostate cancer and other malignancies. We will discuss molecular pathways regulated by soy isoflavones that inhibit survival pathways activated by radiation and ultimately drive the cells to cell death both in vitro and in vivo in pre-clinical models.
Insights
Soy isoflavones enhance radiotherapy effectiveness for prostate cancer. These dietary compounds act as radiosensitizers, improving tumor control and reducing side effects in preclinical models.
Area of Science:
- Oncology
- Nutritional Science
- Radiotherapy
Background:
- Phytochemicals show anti-cancer properties by inhibiting cancer cell proliferation and metastasis.
- Dietary agents can potentiate radiotherapy response and reduce normal tissue toxicity.
- Soy isoflavones are being investigated for their role in cancer chemoprevention and treatment.
Purpose of the Study:
- To review the role of soy isoflavones as radiosensitizers in prostate cancer and other malignancies.
- To discuss the molecular mechanisms by which soy isoflavones enhance radiotherapy efficacy.
- To highlight the potential of dietary factors in improving conventional cancer therapy.
Main Methods:
- Review of preclinical studies using orthotopic models of prostate cancer.
- Investigation of the synergistic effects of soy isoflavones combined with tumor irradiation.
- Analysis of molecular pathways regulated by soy isoflavones in response to radiation.
Main Results:
- Combination of soy isoflavones and tumor irradiation demonstrated synergistic anti-cancer effects.
- Soy isoflavones showed potential in improving tumor growth and metastasis control.
- Evidence suggests soy isoflavones can inhibit radiation-activated survival pathways.
Conclusions:
- Soy isoflavones act as potent radiosensitizers for prostate cancer.
- Dietary factors like soy isoflavones can improve conventional radiotherapy outcomes.
- Further research into soy isoflavones may lead to enhanced cancer treatment strategies.
